Exclusive Psychedelic Drug Development Agreement Secured
Nov 9, 2020
Psilocybin, mescaline, LSD, MDMA, DMT and other psychedelic compounds added to exclusive dealing agreement for the development of psychedelic-based therapeutics Vancouver, Canada (November 09, 2020)...